Dr. Karla M. Kurrelmeyer, MD

Dr. Kurrelmeyer practices at Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas.

Dr. Kurrelmeyer's NPI, 1124063631, was assigned on June 18, 2006. Dr. Kurrelmeyer graduated from University Of Minnesota Medical School in 1993. Dr. Kurrelmeyer holds Texas license K2231.

Dr. Kurrelmeyer's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD, at 6550 Fannin St, Houston, TX 77030.

Dr. Kurrelmeyer's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas. Dr. Kurrelmeyer is also affiliated with Houston Methodist Hospital. The medical group on file is Houston Methodist Specialty Physician Group. Dmand AI also links Dr. Kurrelmeyer to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kurrelmeyer practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kurrelmeyer's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kurrelmeyer is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Kurrelmeyer's licenses on file in 2 states: Texas and Missouri.

Dmand AI lists atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis, chronic hypertension, coronary artery disease, heart blockage and heart failure among the conditions Dr. Kurrelmeyer treats.

CMS data shows 2,452 Medicare services from Dr. Kurrelmeyer across 17 procedure codes in 2024, for 1,296 Medicare patients. Medicare paid $106,138 for them.

CMS counts 1,296 Medicare patients who saw Dr. Kurrelmeyer in 2024. The largest group is 65 to 74, with 543 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kurrelmeyer's median patient age at 73, with 59% women.

In 2024, Dr. Kurrelmeyer wrote 4,943 Medicare Part D claims for 553 patients. 83% of them were for generic drugs. CMS names the drug for 4,658 of them, across 56 drugs with 11 or more claims each, at $862,605 in total drug cost. In 2023, CMS named 4,708 claims across 57 drugs.

Dr. Kurrelmeyer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kurrelmeyer as offering telehealth.

Dmand AI links 25 papers to Dr. Kurrelmeyer, published from 2006 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Heart Failure, Coronary Artery Disease and Cytokines. Dr. Kurrelmeyer has published most often in Methodist Debakey Cardiovasc J. Dr. Kurrelmeyer's most frequent co-authors are Sherif F. Nagueh, MD, Biykem Bozkurt, MD and Dipan Shah, MD.

Dmand AI links Dr. Kurrelmeyer to 1 clinical trial. Conditions studied include Heart Failure, Diastolic and Heart Failure.

CMS Open Payments shows 88 general payments to Dr. Kurrelmeyer from 18 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 45% of the total. Medtronic Vascular, Inc. paid the most, $2,244.

Dmand AI lists 5 awards for Dr. Kurrelmeyer, most recently NCQA HSRP in 2014. Dr. Kurrelmeyer serves on Houston Methodist Hospital System Pharmacy and Therapeutics Committee and American College of Cardiology Membership Committee.

Dr. Kurrelmeyer graduated from University Of Minnesota Medical School in 1993. Dr. Kurrelmeyer is a member of ACC and ASE.

Dr. Kurrelmeyer is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.